Danish drugmaker Bavarian Nordic predicts strong revenue after large new mpox contract
Bavarian Nordic announced on Wednesday that it has signed a contract with an undisclosed European country to provide 440,000 doses of its smallpox and mpox vaccine.The delivery of the vaccines will take place before the end of 2024, and the Danish drugmaker is therefore optimistic on full-year earnings, writing in a stock exchange announcement that […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Yearly subscription
79
DKK/month.
(Billed once a year)
The post Danish drugmaker Bavarian Nordic predicts strong revenue after large new mpox contract appeared first on The Copenhagen Post.